96 related articles for article (PubMed ID: 8938152)
1. Tumoral progression of human breast epithelial cells secreting FGF2 and FGF4.
Souttou B; Gamby C; Crepin M; Hamelin R
Int J Cancer; 1996 Nov; 68(5):675-81. PubMed ID: 8938152
[TBL] [Abstract][Full Text] [Related]
2. Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.
Dell'Era P; Belleri M; Stabile H; Massardi ML; Ribatti D; Presta M
Oncogene; 2001 May; 20(21):2655-63. PubMed ID: 11420677
[TBL] [Abstract][Full Text] [Related]
3. FGF2 as an autocrine growth factor for immortal human breast epithelial cells.
Souttou B; Hamelin R; Crépin M
Cell Growth Differ; 1994 Jun; 5(6):615-23. PubMed ID: 8086338
[TBL] [Abstract][Full Text] [Related]
4. Hyperplasia and impaired involution in the mammary gland of transgenic mice expressing human FGF4.
Morini M; Astigiano S; Mora M; Ricotta C; Ferrari N; Mantero S; Levi G; Rossini M; Barbieri O
Oncogene; 2000 Dec; 19(52):6007-14. PubMed ID: 11146552
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice.
McLeskey SW; Kurebayashi J; Honig SF; Zwiebel J; Lippman ME; Dickson RB; Kern FG
Cancer Res; 1993 May; 53(9):2168-77. PubMed ID: 8481920
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor 3 is tumorigenic for mouse mammary cells orthotopically implanted in nude mice.
Hajitou A; Calberg-Bacq CM
Int J Cancer; 1995 Nov; 63(5):702-9. PubMed ID: 7591288
[TBL] [Abstract][Full Text] [Related]
7. Autocrine growth stimulation by secreted Kaposi fibroblast growth factor but not by endogenous basic fibroblast growth factor.
Wellstein A; Lupu R; Zugmaier G; Flamm SL; Cheville AL; Delli Bovi P; Basilico C; Lippman ME; Kern FG
Cell Growth Differ; 1990 Feb; 1(2):63-71. PubMed ID: 1964794
[TBL] [Abstract][Full Text] [Related]
8. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
[TBL] [Abstract][Full Text] [Related]
9. N-myc oncogene enhances mitogenic responsiveness of diploid human fibroblasts to growth factors but fails to immortalize.
Brondyk WH; Boeckman FA; Fahl WE
Oncogene; 1991 Jul; 6(7):1269-76. PubMed ID: 1861869
[TBL] [Abstract][Full Text] [Related]
10. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
Talarico D; Basilico C
Mol Cell Biol; 1991 Feb; 11(2):1138-45. PubMed ID: 1990270
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation.
Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H
Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor expression induces FGF2, FGF-binding protein production, and FGF2 release in prostate carcinoma cells: role of FGF2 in growth, survival, and androgen receptor down-modulation.
Rosini P; Bonaccorsi L; Baldi E; Chiasserini C; Forti G; De Chiara G; Lucibello M; Mongiat M; Iozzo RV; Garaci E; Cozzolino F; Torcia MG
Prostate; 2002 Dec; 53(4):310-21. PubMed ID: 12430142
[TBL] [Abstract][Full Text] [Related]
13. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
[TBL] [Abstract][Full Text] [Related]
14. Transformation and amplification of the K-fgf proto-oncogene in NIH-3T3 cells, and induction of metastatic potential.
Damen JE; Greenberg AH; Wright JA
Biochim Biophys Acta; 1991 Sep; 1097(2):103-10. PubMed ID: 1911883
[TBL] [Abstract][Full Text] [Related]
15. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats.
Braun L; Goyette M; Yaswen P; Thompson NL; Fausto N
Cancer Res; 1987 Aug; 47(15):4116-24. PubMed ID: 2440558
[TBL] [Abstract][Full Text] [Related]
16. The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7).
Bagheri-Yarmand R; Kourbali Y; Mabilat C; Morère JF; Martin A; Lu H; Soria C; Jozefonvicz J; Crépin M
Br J Cancer; 1998 Jul; 78(1):111-8. PubMed ID: 9662260
[TBL] [Abstract][Full Text] [Related]
17. Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors.
Giavazzi R; Giuliani R; Coltrini D; Bani MR; Ferri C; Sennino B; Tosatti MP; Stoppacciaro A; Presta M
Cancer Res; 2001 Jan; 61(1):309-17. PubMed ID: 11196179
[TBL] [Abstract][Full Text] [Related]
18. Basic fibroblast growth factor in an animal model of spontaneous mammary tumor progression.
Kao S; Mo J; Baird A; Eliceiri BP
Oncol Rep; 2012 Jun; 27(6):1807-14. PubMed ID: 22407271
[TBL] [Abstract][Full Text] [Related]
19. Inducible expression of FGF-3 in mouse mammary gland.
Ngan ES; Ma ZQ; Chua SS; DeMayo FJ; Tsai SY
Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11187-92. PubMed ID: 12169667
[TBL] [Abstract][Full Text] [Related]
20. Protection of mice against tumor growth by immunization with an oncogene-encoded growth factor.
Talarico D; Ittmann M; Balsari A; Delli-Bovi P; Basch RS; Basilico C
Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4222-5. PubMed ID: 2190216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
